Maggie S Burhans

Title: Innovations of Maggie S Burhans in Glucoregulatory Dysfunction

Introduction

Maggie S Burhans is a notable inventor based in Madison, WI (US). She has made significant contributions to the field of glucoregulatory dysfunction through her innovative research and patented methods. Her work focuses on identifying individuals at risk for glucoregulatory dysfunction, which is crucial for developing effective therapeutic interventions.

Latest Patents

Maggie S Burhans holds a patent titled "Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations." This patent provides reagents, methods, and biochemical markers for identifying individuals with glucoregulatory dysfunction. Specifically, it outlines methods for identifying a subject with glucoregulatory dysfunction based on changes in fasting blood lipid concentrations, including diacylglycerols. She has 1 patent to her name.

Career Highlights

Maggie is associated with the Wisconsin Alumni Research Foundation, where she continues to advance her research in the field. Her work has the potential to impact the lives of many individuals by providing early identification and intervention strategies for glucoregulatory dysfunction.

Collaborations

Maggie has collaborated with esteemed colleagues such as Rozalyn M Anderson and Dhanansayan Shanmuganayagam. These collaborations enhance the depth and breadth of her research, contributing to the overall advancement of knowledge in her field.

Conclusion

Maggie S Burhans is a pioneering inventor whose work in glucoregulatory dysfunction is paving the way for innovative solutions in healthcare. Her contributions are vital for improving the identification and treatment of individuals at risk for this condition.